In addition, pretreatment of TGF-β1 could prevent the elevation of Aβ-induced proinflammatory mediators and regulate the expression of proapoptotic and antiapoptotic factors, leading to neuroprotection in AD models [28, 30]. The gene discussed is TGFB1; the disease is Alzheimer disease.